Epicrispr Biotechnologies focuses on developing advanced gene editing solutions to treat genetic disorders. It aims to leverage CRISPR technology to create effective therapies for patients with unmet medical needs.
Founded
2018
Total Funding
$100M+
Total Rounds
3
First Raise
Mar 26, 2025
Latest Raise
Aug 11, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/11/2026 | |||
2 more funding rounds available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free